Cargando…
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
The development of cancer vaccines has been intensively pursued over the past 50 years with modest success. However, recent advancements in the fields of genetics, molecular biology, biochemistry, and immunology have renewed interest in these immunotherapies and allowed the development of promising...
Autores principales: | Tay, Ban Qi, Wright, Quentin, Ladwa, Rahul, Perry, Christopher, Leggatt, Graham, Simpson, Fiona, Wells, James W., Panizza, Benedict J., Frazer, Ian H., Cruz, Jazmina L. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160852/ https://www.ncbi.nlm.nih.gov/pubmed/34065557 http://dx.doi.org/10.3390/vaccines9050535 |
Ejemplares similares
-
Investigating T Cell Immunity in Cancer: Achievements and Prospects
por: Zeng, Zhen, et al.
Publicado: (2021) -
PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy
por: Wright, Quentin, et al.
Publicado: (2021) -
Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failure
por: Causer, Andrew, et al.
Publicado: (2023) -
Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients
por: Linedale, Richard, et al.
Publicado: (2017) -
Cytokine/chemokine profiles in squamous cell carcinoma correlate with precancerous and cancerous disease stage
por: Tuong, Zewen K., et al.
Publicado: (2019)